These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 24992214

  • 1. Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry.
    González-Domínguez R, García-Barrera T, Gómez-Ariza JL.
    J Pharm Biomed Anal; 2014 Sep; 98():321-6. PubMed ID: 24992214
    [Abstract] [Full Text] [Related]

  • 2. Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP/PS1 transgenic model of Alzheimer's disease.
    González-Domínguez R, García-Barrera T, Vitorica J, Gómez-Ariza JL.
    J Pharm Biomed Anal; 2015 Mar 25; 107():378-85. PubMed ID: 25656489
    [Abstract] [Full Text] [Related]

  • 3. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
    González-Domínguez R, García-Barrera T, Gómez-Ariza JL.
    Anal Bioanal Chem; 2014 Nov 25; 406(28):7137-48. PubMed ID: 25230597
    [Abstract] [Full Text] [Related]

  • 4. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease.
    González-Domínguez R, García-Barrera T, Gómez-Ariza JL.
    J Pharm Biomed Anal; 2015 Mar 25; 107():75-81. PubMed ID: 25575172
    [Abstract] [Full Text] [Related]

  • 5. Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry.
    González-Domínguez R, García A, García-Barrera T, Barbas C, Gómez-Ariza JL.
    Electrophoresis; 2014 Dec 25; 35(23):3321-30. PubMed ID: 25136972
    [Abstract] [Full Text] [Related]

  • 6. Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients.
    Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M.
    Electrophoresis; 2013 Oct 25; 34(19):2865-72. PubMed ID: 23857558
    [Abstract] [Full Text] [Related]

  • 7. Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry.
    González-Domínguez R, García-Barrera T, Vitorica J, Gómez-Ariza JL.
    J Pharm Biomed Anal; 2015 Jan 25; 102():425-35. PubMed ID: 25459942
    [Abstract] [Full Text] [Related]

  • 8. A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease.
    Greenberg N, Grassano A, Thambisetty M, Lovestone S, Legido-Quigley C.
    Electrophoresis; 2009 Apr 25; 30(7):1235-9. PubMed ID: 19288586
    [Abstract] [Full Text] [Related]

  • 9. Direct infusion mass spectrometry for metabolomic phenotyping of diseases.
    González-Domínguez R, Sayago A, Fernández-Recamales Á.
    Bioanalysis; 2017 Jan 25; 9(1):131-148. PubMed ID: 27921460
    [Abstract] [Full Text] [Related]

  • 10. Metabolomic investigation of systemic manifestations associated with Alzheimer's disease in the APP/PS1 transgenic mouse model.
    González-Domínguez R, García-Barrera T, Vitorica J, Gómez-Ariza JL.
    Mol Biosyst; 2015 Sep 25; 11(9):2429-40. PubMed ID: 26131452
    [Abstract] [Full Text] [Related]

  • 11. Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer's Disease.
    Bhawal R, Fu Q, Anderson ET, Gibson GE, Zhang S.
    Int J Mol Sci; 2021 Dec 07; 22(24):. PubMed ID: 34947984
    [Abstract] [Full Text] [Related]

  • 12. Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer's Disease Using Direct Infusion Mass Spectrometry.
    Anand S, Barnes JM, Young SA, Garcia DM, Tolley HD, Kauwe JSK, Graves SW.
    J Alzheimers Dis; 2017 Dec 07; 59(1):277-290. PubMed ID: 28598845
    [Abstract] [Full Text] [Related]

  • 13. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
    Zhang AH, Sun H, Han Y, Yan GL, Yuan Y, Song GC, Yuan XX, Xie N, Wang XJ.
    Anal Chem; 2013 Aug 06; 85(15):7606-12. PubMed ID: 23845028
    [Abstract] [Full Text] [Related]

  • 14. Analytical strategies in lipidomics and applications in disease biomarker discovery.
    Hu C, van der Heijden R, Wang M, van der Greef J, Hankemeier T, Xu G.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep 15; 877(26):2836-46. PubMed ID: 19233743
    [Abstract] [Full Text] [Related]

  • 15. A Targeted Mass Spectrometry Approach to Identify Peripheral Changes in Metabolic Pathways of Patients with Alzheimer's Disease.
    Reveglia P, Paolillo C, Angiolillo A, Ferretti G, Angelico R, Sirabella R, Corso G, Matrone C, Di Costanzo A.
    Int J Mol Sci; 2023 Jun 04; 24(11):. PubMed ID: 37298687
    [Abstract] [Full Text] [Related]

  • 16. Lipidomic and metabolomic analyses reveal potential plasma biomarkers of early atheromatous plaque formation in hamsters.
    Jové M, Ayala V, Ramírez-Núñez O, Serrano JC, Cassanyé A, Arola L, Caimari A, Del Bas JM, Crescenti A, Pamplona R, Portero-Otín M.
    Cardiovasc Res; 2013 Mar 15; 97(4):642-52. PubMed ID: 23241314
    [Abstract] [Full Text] [Related]

  • 17. Lipidomics of Alzheimer's disease.
    Touboul D, Gaudin M.
    Bioanalysis; 2014 Feb 15; 6(4):541-61. PubMed ID: 24568356
    [Abstract] [Full Text] [Related]

  • 18. Metabolomics in Alzheimer's disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology.
    González-Domínguez R, Sayago A, Fernández-Recamales Á.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec 15; 1071():75-92. PubMed ID: 28189423
    [Abstract] [Full Text] [Related]

  • 19. Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease.
    González-Domínguez R, García-Barrera T, Gómez-Ariza JL.
    J Proteomics; 2014 Jun 02; 104():37-47. PubMed ID: 24473279
    [Abstract] [Full Text] [Related]

  • 20. Application of a novel metabolomic approach based on atmospheric pressure photoionization mass spectrometry using flow injection analysis for the study of Alzheimer's disease.
    González-Domínguez R, García-Barrera T, Gómez-Ariza JL.
    Talanta; 2015 Jan 02; 131():480-9. PubMed ID: 25281130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.